Sarcoidosis in melanoma patients: Case report and literature review

Cancers

Volumn 7, Issue 2, 2015, Pages 1005-1021

  Beutler, Bryce D ^a   Cohen, Philip R ^b  

^a UNIVERSITY OF NEVADA   (United States)

^b San Diego   (United States)

Author keywords

Cancer; Cutaneous; Malignancy; Melanoma; Sarcoid; Sarcoidosis; Solid tumors

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; BETA INTERFERON; BETAMETHASONE DIPROPIONATE; CD68 ANTIGEN; CISPLATIN; CORTICOSTEROID; CYTOKERATIN AE1; CYTOKERATIN AE3; DACARBAZINE; GLUCOSE; HYDROXYCHLOROQUINE; INTERFERON; INTERLEUKIN 2; IPILIMUMAB; LIQUID NITROGEN; MECLOZINE; MELAN A; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PREDNISONE; VEMURAFENIB; VINDESINE;

ACTINIC KERATOSIS; ANTIGEN RECOGNITION; AUTOIMMUNITY; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CARDIOMYOPATHY; CASE REPORT; CELL PROLIFERATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRYOTHERAPY; DISEASE DURATION; DIZZINESS; ENVIRONMENTAL EXPOSURE; FACE INJURY; GRANULOMA; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEG PAIN; LUMBAR PUNCTURE; LUNG LAVAGE; LUNG SARCOIDOSIS; MALE; MELANOCYTE; MELANOMA; METASTATIC MELANOMA; NAUSEA; NERVE CONDUCTION; PARESTHESIA; REVIEW; SARCOIDOSIS; SCALY ANNULAR VIOLACEOUS PLAQUE; SKIN BIOPSY; SKIN DISEASE; SPINDLE CELL; THORAX INJURY; TINNITUS; ULTRAVIOLET RADIATION;

EID: 84934918449     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers7020821     Document Type: Review

References (55)

1. Fernandez-Faith, E.; McDonnell, J. Cutaneous sarcoidosis: Differential diagnosis. Clin. Dermatol. 2007, 25, 276–287.
2. Sharma, O.P. Sarcoidosis of the skin. In Fitzpatrick’s Dermatology in General Medicine, 5th ed.; Freedberg, I.M., Fitzpatrick, T.B., Eds.; McGraw-Hill: New York, NY, USA, 1999; pp. 2099–2106.
3. Blake, T.; Manahan, M.; Rodins, K. Erythema nodosum—A review of an uncommon panniculitis. Dermatol. Online J. 2014, 20, 22376
4. Cather, J.C.; Menter, M.A. Hair loss and plaquelike skin lesions. Proc. (Bayl. Univ. Med. Cent.) 2001, 14, 101–103
5. Tchernev, G.; Cardoso, J.C.; Chokoeva, A.A.; Verma, S.B.; Tana, C.; Ananiev, J.; Gulubova, M.; Philipov, S.; Kanazawa, N.; Nenoff, P. et al. The “mystery” of cutaneous sarcoidosis: Facts and controversies. Int. J. Immunopathol. Pharmacol. 2014, 27, 321–330.
6. Mañá, J.; Marcoval, J.; Graells, J.; Salazar, A.; Peyrí, J.; Pujol, R. Cutaneous involvement in sarcoidosis: Relationship to systemic disease. Arch. Dermatol. 1997, 133, 882–888.
7. Cather, J.C.; Cohen, P.R. Icthyosiform sarcoidosis. J. Am. Acad. Dermatol. 1999, 40, 862–865.
8. Singh, L.; Aboutalebi, S.; Smith, J. Subcutaneous sarcoidosis in a melanoma scar. Cutis 2011, 87, 234–236.
9. Seve, P.; Schott, A.M.; Pavic, M.; Broussolle, C.; Gilis, L.; Thomas, L. Sarcoidosis and melanoma: A referral center study of 1,199 cases. Dermatology 2009, 219, 25–31.
10. 10. Murphy, K.P.; Kennedy, M.P.; Barry, J.E.; O’Regan, K.N.; Power, D.G. New-onset mediastinal and central nervous system sarcoidosis in a patient with metastatic melanoma undergoing CTLA4 monoclonal antibody treatment. Oncol. Res. Treat. 2014, 37, 351–353.
11. Ginat, D.T.; Dhillon, G.; Almast, J. Magnetic resonance imaging of neurosarcoidosis. J. Clin. Imaging Sci. 2011, 1, 15.
12. Herxheimer, G. Uber karzinoma und tuberkulose. Z. Tuberk. 1917, 27, 251–258.
13. Pautrier, L.M. Cas extraordinaire de sarcoides dermiques noueuses disseminées. Bull. Soc. Franc. Derm. Syph. 1934, 41, 1233–1252.
14. Brincker, H. Sarcoid reactions and sarcoidosis in Hodgkin’s disease and other malignant lymphomata. Br. J. Cancer 1972, 26, 120–123.
15. Horwitz, O.; Payne, P.G.; Wilbek, E. Epidemiology of sarcoidosis in Denmark. Dan Med. Bull. 1967, 14, 178–182.
16. Brincker, H.; Wilbek, E. The incidence of malignant tumours in patients with respiratory sarcoidosis. Br. J. Cancer 1974, 29, 247–251.
17. Reich, J.M.; Mullooly, J.P.; Johnson, R.E. Linkage analysis of malignancy-associated sarcoidosis. Chest 1995, 107, 605–613.
18. Chaigne, B.; Perrinaud, A.; Penaud, A.; Machet, M.C.; Venel, Y.; Marchand-Adam, S.; Machet, L. Melanoma lymph node metastasis occurring simultaneously with multifocal sarcoidosis affecting lymph nodes and the lung: A diagnostic pitfall. Eur. J. Dermatol. 2011, 21, 798–799.
19. Rubinstein, I.; Baum, G.L.; Yellin, A.; Herczeg, E. Sarcoidosis: A cause of bilateral hilar lymphadenopathy after excision of malignant melanoma of the arm. South. Med. J. 1985, 78, 1139–1140.
20. Robert, C.; Schoenlaub, P.; Avril, M.F.; Lok, C.; Grosshans, E.; Valeyre, D.; Bourgeois, C.; Pinquier, L.; Dubertret, L.; Guillaume, J.C. Malignant melanoma and granulomatosis. Br. J. Dermatol. 1997, 137, 787–792.
21. Mahood, J.M. Malignant melanoma arising from a congenital pigmented naevus in a patient with sarcoidosis: Cause or coincidence? Clin. Exp. Dermatol. 2006, 31, 665–667.
22. Malli, F.; Gourgoulianis, K.I.; Daniil, Z. Concurrent sarcoidosis and melanoma: Coexistence more than by chance? Dermatology 2010, 221, 320.
23. Mackenzie, H.; Retsas, S. Malignant melanoma co-existing with sarcoidosis: Implications for prognosis and management. Melanoma Res. 1996, 6, 71–72.
24. Haluska, P.; Luetmer, P.H.; Inwards, C.Y.; Afessa, B.; Shives, T.C.; Ingle, J.N. Complications of therapy and a diagnostic dilemma case. Case 3. Diagnostic dilemma: A sarcoidosis simulating metastatic malignancy. J. Clin. Oncol. 2003, 21, 4653–4654.
25. Echigo, T.; Saito, A.; Takehara, K.; Takata, M.; Hatta, N. Coexistence of micrometastatic melanoma cells and sarcoid granulomas in all regional lymph nodes in a patient with acral melanoma. Clin. Exp. Dermatol. 2003, 28, 375–376.
26. Meristoudis, G.; Tsaroucha, A.; Ilias, I.; Giannakopoulos, V.; Batsakis, C.; Christakopoulou, J. Interferon-induced sarcoidosis with osseous involvement in a patient with melanoma. Hell. J. Nucl. Med. 2011, 14, 68–69.
27. Vogel, W.V.; Guislain, A.; Kvistborg, P.; Schumacher, T.N.; Haanen, J.B.; Blank, C.U. Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission. J. Clin. Oncol. 2012, 30, e7–e10.
28. Alonso-Perez, A.; Ballestero-Diez, M.; Fraga, J.; Garcia-Diaz, A.; Fernandez-Herrera, J. Cutaneous sarcoidosis by interferon therapy in a patient with melanoma. J. Eur. Acad. Dermatol. Venereol. 2006, 20, 1328–1329.
29. Adam, A.; Thomas, L.; Bories, N.; Zaharia, D.; Balme, B.; Freymond, N.; Dalle, S. Sarcoidosis associated with vemurafenib. Br. J. Dermatol. 2013, 169, 206–208.
30. Suarez-Garcia, C.; Perez-Gil, A.; Pereira-Gallardo, S.; Codes-Villena, M.; Garcia-Escudero, A.; Miguel Camacho, F. Interferon-induced cutaneous sarcoidosis in melanoma. Melanoma Res. 2009, 19, 391–394.
31. Shiki, M.; Hida, T.; Yamashita, T. Development of sarcoidosis during β-interferon therapy for melanoma. J. Dermatol. 2014, 41, 862–863.
32. Heinzerling, L.M.; Anliker, M.D.; Muller, J.; Schlaeppi, M.; von Moos, R. Sarcoidosis induced by interferon-alpha in melanoma patients: Incidence, clinical manifestations, and management strategies. J. Immunother. 2010, 33, 834–839.
33. Wilgenhof, S.; Morlion, V.; Seghers, A.C.; Du Four, S.; Vanderlinden, E.; Hanon, S.; Vandenbroucke, F.; Everaert, H.; Neyns, B. Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor. Anticancer Res. 2012, 32, 1355–1359.
34. Toulemonde, A.; Quereux, G.; Dreno, B. Sarcoidosis granuloma on a tattoo induced by interferon alpha. Ann. Dermatol. Venereol. 2004, 131, 49–51,
35. Hendrickx, B.W.; van Herpen, C.M.; Bonenkamp, J.J.; Bulten, J.; Oyen, W.J. Positive positron emission tomography scan in sarcoidosis and two challenging cases of metastatic cancer. Case 1. Mediastinal sarcoidosis in a melanoma patient treated with interferon. J. Clin. Oncol. 2005, 23, 8906–8907.
36. North, J.; Mully, T. Alpha-interferon induced sarcoidosis mimicking metastatic melanoma. J. Cutan. Pathol. 2011, 38, 585–589.
37. Pelletier, F.; Manzoni, P.; Jacoulet, P.; Humbert, P.; Aubin, F. Pulmonary and cutaneous sarcoidosis associated with interferon therapy for melanoma. Cutis 2007, 80, 441–445.
38. Eckert, A.; Schoeffler, A.; Dalle, S.; Phan, A.; Kiakouama, L.; Thomas, L. Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient. Dermatology 2009, 218, 69–70.
39. Jeon, E.K.; Hong, J.; Hong, S.H.; Kang, J.Y.; Park, G.; Ahn, M.I.; Lee, J.Y.; Kang, J. First reported case of interferon-alpha-induced sarcoidosis in an Asian patient with malignant melanoma. Asia Pac. J. Clin. Oncol. 2014.
40. Askling, J.; Grunewald, J.; Eklund, A.; Hillerdal, G.; Ekbom, A. Increased risk for cancer following sarcoidosis. Am. J. Respir. Crit. Care Med. 1999, 60, 1668–1672.
41. Marlier, J.; Cocquyt, V.; Brochez, L.; Van Belle, S.; Kruse, V. Ipilimumab, not just another anti-cancer therapy: Hypophysitis as side effect illustrated by four case-reports. Endocrine 2014, 47, 878–883.
42. Massaguer, S.; Sanchez, M.; Castel, T. Mediastinal sarcoidosis induced by high-dose alpha-2-inteferon therapy in a patient with malignant melanoma. Eur. Radiol. 2004, 14, 1716–1717.
43. Romer, F.K.; Hommelgaard, P.; Schou, G. Sarcoidosis and cancer revisited: A long-term follow-up study of 555 Danish sarcoidosis patients. Eur. Respir. J. 1998, 12, 906–912.
44. Seersholm, N.; Vestbo, J.; Viskum, K. Risk of malignant neoplasms in patients with pulmonary sarcoidosis. Thorax 1997, 52, 892–894.
45. Yserbyt, J.; Ninane, V. Aggravating cough in a patient with suspected sarcoidosis. Thorax 2013, 68, 117–118.
46. Bazzoni, F.; Kruys, V.; Shakhov, A.; Jongeneel, C.V.; Beutler, B. Analysis of tumor necrosis factor promoter reponses to ultraviolet light. J. Clin. Investig. 1994, 93, 56–62.
47. Ji, J.; Shu, X.; Li, X.; Sundguist, K.; Sundguist, J.; Hemminki, K. Cancer risk in hospitalized sarcoidosis patients: A follow-up study in Sweden. Ann. Oncol. 2009, 20, 1121–1126.
48. Shu, X.; Ji, J.; Sundguist, K.; Sundguist, J.; Hemminki, K. Survival in cancer patients with previous hospitalization for sarcoidosis: A Swedish population-based cohort study during 1964–2006. Ann. Oncol. 2011, 22, 1427–1434.
49. Boffetta, P.; Rabkin, C.S.; Gridley, G. A cohort study of cancer among sarcoidosis patients. Int. J. Cancer 2009, 124, 2697–2700.
50. Cohen, P.R.; Kurzrock, R. Sarcoidosis and malignancy. Clin. Dermatol. 2007, 25, 326–333.
51. Tana, C.; Giamberardino, M.A.; Di Gioacchino, M.; Mezzetti, A.; Schiavone, C. Immunopathogenesis of sarcoidosis and risk of malignancy: A lost truth? Int. J. Immunopathol. Pharmacol. 2013, 26, 305–313.
52. Tchernev, G.; Tana, C.; Schiavone, C.; Cardoso, J.C.; Ananiev, J.; Wollina, U. Sarcoidosis vs. sarcoid-like reactions: The two sides of the same coin? Wien. Med. Wochenschr. 2014, 164, 247–259.
53. Tsunoda, K.; Onodera, H.; Akasaka, T. Case of malignant melanoma associated with a sarcoid reaction. J. Dermatol. 2011, 38, 939–942.
54. Chokoeva, A.A.; Tchernev, G.; Tana, C.; Ananiev, J.; Wollina, U. Sarcoid-like pattern in a patient with tuberculosis. J. Biol. Regul. Homeost. Agents 2014, 28, 783–788.
55. Chokoeva, A.A.; Tchernev, G.; Tana, M.; Tana, C. Exclusion criteria for sarcoidosis: A novel approach for an ancient disease? Eur. J. Intern. Med. 2014, 25, e120.